The management of neuropathic pain with a focus upon older adults

American Journal of Therapeutics

Volumn 19, Issue 3, 2012, Pages 211-227

  McCarberg, Bill ^a,b   Barkin, Robert L ^c   Zaleon, Carolyn ^d  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

anesthetics; antidepressants; antiseizure agents; elderly; neuropathic pain; opioids; patient focused; patientspecific treatment; personalized pharmacotherapeutic care

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; CAPSAICIN; CLONIDINE; DESIPRAMINE; DULOXETINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MEXILETINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; NORTRIPTYLINE; OPIATE; OXYCODONE; PREGABALIN; TAPENTADOL; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

AGING; ALLODYNIA; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; BLURRED VISION; CARDIOTOXICITY; COGNITIVE DEFECT; CONSTIPATION; CONSULTATION; DEPRESSION; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHY; DIARRHEA; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DYSPEPSIA; HUMAN; HYPERTENSION; IN VITRO STUDY; IRRITABILITY; LIVER DYSFUNCTION; LONG TERM CARE; MENTAL HEALTH; NAUSEA; NERVOUSNESS; NEUROPATHIC PAIN; NEUROPATHIC PAIN SCALE; NEUROPHYSIOLOGY; NOCICEPTIVE PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRESCRIPTION; PRIORITY JOURNAL; QT PROLONGATION; QUESTIONNAIRE; RATING SCALE; REBOUND HYPERTENSION; REVIEW; SEIZURE; SIDE EFFECT; STANDING; STEVENS JOHNSON SYNDROME; STOMACH PARESIS; TOXIC EPIDERMAL NECROLYSIS; TREATMENT RESPONSE; TREMOR; UNITED STATES; VOMITING; WEAKNESS; WEIGHT GAIN;

AGE FACTORS; AGED; ANALGESICS; ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; HUMANS; INDIVIDUALIZED MEDICINE; NEURALGIA; PATIENT-CENTERED CARE; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 84861185857     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31822119b3     Document Type: Review

References (59)

1. Centers for Disease Control. Healthy Aging: Preventing Disease and Improving Quality of Life Among Older Americans. Atlanta, GA: CDC; 2001.
2. Ferrell BA. Pain management in elderly people. J Am Geriatr Soc. 1991;39:64-73.
3. Stein WM, Miech RP. Cancer pain in the elderly hospice patient. J Pain Symptom Manage. 1993;8:474-482. (Pubitemid 23292528)
4. Otis JAD, McGeeney B. Managing pain in the elderly. Clin Geriatr. 2001;9:82-88.
5. Ferrell BA, Ferrell BR, Osterweil D. Pain in the nursing home. J Am Geriatr Soc. 1990;38:409-414. (Pubitemid 20146170)
6. Gaston-Johansson F, Johansson F, Johansson N. Under-treatment of pain in the elderly: causes and prevention. Ann Long-Term Care. 1999;7:190-196. (Pubitemid 29289480)
7. Mobily P, Herr K. Barriers to managing resident's pain. Contemp Long Term Care. 1996;19:60A-60B.
8. Ferrell BA. Pain evaluation and management in the nursing home. Ann Intern Med. 1995;123:681-687
9. American geriatrics society panel on chronic pain in older persons. AGS clinical practice guidelines: the management of chronic pain in older persons. J Am Geriatr Soc. 1998;46:635-651.
10. American medical directors association. Chronic Pain Management in the Long-Term Care Setting: Clinical Practice Guideline. Baltimore, MD: American Medical Directors Association; 1999.
11. Verdu E, Ceballos D, Vilches JJ, et al. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst. 2000;5:191-208. (Pubitemid 32037991)
12. Drac H, Babiuch M, Wisniewska W. Morphological and biochemical changes in peripheral nerves with aging. Neuropathol Polska. 1991;29:49-67.
13. Knox CA, Kokmen E, Dyck PJ. Morphometric alteration of rat myelinated fibres with aging. J Neuropathol Exp Neurol. 1989;48:119-139. (Pubitemid 19073973)
14. Kakigi R. The effect of aging on somatosensory evoked potentials following stimulation of the posterior tibial nerve in man. Electroencephalogr Clin Neurophysiol. 1987; 68:227-286.
15. Alder G, Nacimiento AC. Age-dependent changes in short-latency somatosensory evoked potentials in healthy adults. Appl Neurophysiol. 1988;51:55-59.
16. Prineas JW, Spencer PS. Pathology of the nerve cell body in disorders of the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, eds. Peripheral Neuropathy. Philadelphia, PA: W B Saunders; 1975:253-295.
17. Ko ML, King MA, Gordon TL, et al. The effects of aging on spinal neurochemistry in the rat. Brain Res Bull. 1997; 42:95-98.
18. Iwata K, Fukuoka T, Kondo E, et al. Plastic changes in nociceptive transmission of the rat spinal cord with advancing age. J Neurophysiol. 2002;87:1086-1093. (Pubitemid 34670870)
19. Chapman CR, Casey KL, Dubner R, et al. Pain measurement: an overview. Pain. 1985;22:1-31. (Pubitemid 15037578)
20. Gracely RH, Lota L, Walter DJ, et al. A multiple random staircase method of psychophysical pain assessment. Pain. 1988;32:55-63.
21. Beck AT, Ward C, Mendelson M. Beck Depression Inventory (BDI). Arch Gen Psychiatr. 1961;4:561-571.
22. Weiner DK, Peterson BL, Logue P, et al. Predictors of pain self-report in nursing home residents. Aging Clin Exp Res. 1998;10:411-420.
23. Galer B, Jensen M. Development and preliminary validation of a pain measure specific to neuropathic pain. The neuropathic pain scale. Neurology. 1997;48:332-338. (Pubitemid 27087598)
24. Bennett M. The LANSS pain scale. The Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147-157. (Pubitemid 32367946)
25. Pollard CA. Preliminary validity study of the pain disability index. Percept Mot Skills. 1984;59:974.
26. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain. 1983;17: 33-44. (Pubitemid 13004472)
27. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985; 23:345-356. (Pubitemid 16212847)
28. Ferrell BA. Overview of aging and pain. In: Ferrell BA, Ferrell BR, eds. Pain in the Elderly. Seattle, WA: IASP Press; 1996:1-10
29. American geriatrics society panel on persistent pain in older persons. The management of persistent pain in older persons. J Am Ger Soc. 2002;50:S205-S224.
30. Wolfe GI, Trivedi JR. Painful peripheral neuropathy and it nonsurgical treatment. Muscle Nerve. 2004;30:3-19. (Pubitemid 38880320)
31. Dworkin RH, O'Connor AB, Backonja M, et al. Pharma-cologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-251. (Pubitemid 350051570)
32. Stacey BR. Management of peripheral neuropathic pain. Am J Phys Med Rehabil. 2005;84:S4-S16. (Pubitemid 40256221)
33. Duby JJ, Campbell RK, Setter SM, et al. Diabetic neuropathy: an intensive review. Am J Health-Syst Pharm. 2004;61:160-176. (Pubitemid 39004640)
34. Guay DRP. Adjunctive agents in the management of chronic pain. Pharmacotherapy. 2001;21:1070-1081. (Pubitemid 32807868)
35. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Brunton LL, ed. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006
36. Lacy CF, Armstrong LL, Goldman MP, et al, eds. Drug Information Handbook. 16th ed. Hudson, OH: Lexi-Comp, Inc; 2008-2009.
37. Cymbalta . [Product information]. Indianapolis, IN: Eli Lilly and Company; 2008.
38. Effexor XR . [Product information]. Philadelphia, PA: Wyeth Pharmaceuticals, Inc; 2008.
39. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology. 2001;57:1583-1588. (Pubitemid 33055474)
40. Lyrica®. [Product information]. New York, NY: Parke-Davis, Division of Pfizer; 2007.
41. Neurontin . [Product information]. New York, NY: Parke-Davis, Division of Pfizer; 2007.
42. McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology. 1994;44(Suppl 5):S17-S22.
43. McNamara JO. Pharmacotherapy of the epilepsies. In: Brunton LL, ed. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006.
44. Depakote ER . [Product information]. North Chicago, IL: Abbott Laboratories, Inc; 2008.
45. Lamictal®. [Product information]. Research Triangle Park, NC: GlaxoSmithKline; 2007.
46. Topamax . [Product information]. Titusville, NJ: Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc; 2008.
47. Carroll DG, Kline KM, Malnar KF. Role of topiramate for the treatment of painful diabetic peripheral neuropathy. Pharmacotherapy. 2004;24:1186-1193 (Pubitemid 39128842)
48. Dunteman ED. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary. J Pain Pall Care Pharmacother. 2005;19:35-43. (Pubitemid 40594048)
49. Keppra®. [Product Information]. Smyrna GA: UCB Inc; 2008.eFacts and comparisons 4.0\-doxepin hydrochloride topical monograph. Available at: http://online.factsandcomparisons.com.proxy.lib.umich.edu/MonoDisp.aspx?book= DFC&monoID=fandchcp14419&nostem=False& searched=doxepin. Accessed September 1, 2010.
50. Lidoderm . [Product information]. Chadds Ford, PA: Endo Pharmaceuticals, Inc; 2008.
51. Fox LP, Merk HF, Bickers DR. Dermatological pharmacology. In: Brunton, LL ed. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006.
52. McCleane G. Topical use of nitrates, capsaicin and tricyclic antidepressants for pain management. Adv Stud Med. 2003;3:S631-S634. (Pubitemid 37051894)
53. Ultram ER . [Product information]. Raritan, NJ: PriCara, a unit of Ortho-McNeill, Inc; 2007.
54. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA. 2005;293:3043-3052.
55. Barkin R. Tapentadol: a pharmacotherapeutic focused brief review. Pain Med Netw. 24; 2009:8-11.
56. Gutstein HB, Akil H. Opioid analgesics. In: Brunton LL, ed. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006.
57. Generali J, Cada DJ. Off-label drug uses, dextromethorphan: neuropathy. Hosp Pharm. 2001;36:421-422,424-425.
58. Frese A, Husstedt IW, Ringelstein EB, et al. Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22:252-260. (Pubitemid 44378547)
59. Hall RCW, Hall RCW, Chapman MJ. Central serotonin syndrome: part II\-pathophysiology, drug interactions, and treatment. Clin Geriatr. 2006;22:252-260.